People · Operator

Claude Allary

Named in public records as an officer, director or promoter · active 2014–2026 · Biotechnology

2
Companies
3
Filings
$2.1M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Biophytis SABiotechnologySeed$1.6M$3.0M2026
Arch Biopartners Inc.BiotechnologyPre-Seed$561K$14.6M2014
Operator network

Claude Allary at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Stanislas Veillet · 2 companies · 1 sharedStanislas VeilletChiara Baccelli · 1 companies · 1 sharedChiara BaccelliChristophe Courtillat · 1 companies · 1 sharedChristophe Courti…Edouard Bieth · 1 companies · 1 sharedEdouard BiethJean Mariani · 1 companies · 1 sharedJean MarianiNadine Coulm · 1 companies · 1 sharedNadine CoulmPierre Dilda · 1 companies · 1 sharedPierre DildaWaly Dioh · 1 companies · 1 sharedWaly DiohAdrian Haigh · 2 companies · 1 sharedAdrian HaighAndrew Bishop · 2 companies · 1 sharedAndrew BishopConor Gunne · 1 companies · 1 sharedConor GunneDaniel Muruve · 1 companies · 1 sharedDaniel MuruveRichard Muruve · 1 companies · 1 sharedRichard MuruveRichard Rossman · 1 companies · 1 sharedRichard RossmanBiophytis SA · $1.6M raisedBiophytis SAArch Biopartners Inc. · $0.6M raisedArch Biopartners Inc.Claude AllaryCA
Claude Allary Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Claude Allary on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Andrew Bishop12
Stanislas Veillet12
Adrian Haigh12
Richard Rossman11
Conor Gunne11
Edouard Bieth11
Jean Mariani11
Waly Dioh11
Chiara Baccelli11
Nadine Coulm11
Pierre Dilda11
Christophe Courtillat11
Richard Muruve11
Daniel Muruve11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.